Multiple beta 1 integrins mediate enhancement of human airway smooth muscle cytokine secretion by fibronectin and type I collagen.
Altered airway smooth muscle (ASM) function and enrichment of the extracellular matrix (ECM) with interstitial collagen and fibronectin are major pathological features of airway remodeling in asthma. We have previously shown that these ECM components confer enhanced ASM proliferation in vitro, but their action on its newly characterized secretory function is unknown. Here, we examined the effects of fibronectin and collagen types I, III, and V on IL-1beta-dependent secretory responses of human ASM cells, and characterized the involvement of specific integrins. Cytokine production (eotaxin, RANTES, and GM-CSF) was evaluated by ELISA, RT-PCR, and flow cytometry. Function-blocking integrin mAbs and RGD (Arg-Gly-Asp)-blocking peptides were used to identify integrin involvement. IL-1beta-dependent release of eotaxin, RANTES, and GM-CSF was enhanced by fibronectin and by fibrillar and monomeric type I collagen, with similar changes in mRNA abundance. Collagen types III and V had no effect on eotaxin or RANTES release but did modulate GM-CSF. Analogous changes in intracellular cytokine accumulation were found, but in <25% of the total ASM cell population. Function-blocking Ab and RGD peptide studies revealed that alpha2beta1, alpha5beta1, alphavbeta1, and alphavbeta3 integrins were required for up-regulation of IL-1beta-dependent ASM secretory responses by fibronectin, while alpha2beta1 was an important transducer for type I collagen. Thus, fibronectin and type I collagen enhance IL-1beta-dependent ASM secretory responses through a beta1 integrin-dependent mechanism. Enhancement of cytokine release from ASM by these ECM components may contribute to airway wall inflammation and remodeling in asthma.
Peng
Qi
Q
Department of Asthma, Allergy and Respiratory Science, The Guy's, King's and St. Thomas' School of Medicine, King's College London, Guy's Hospital Campus, London, United Kingdom.
Lai
Dilys
D
Nguyen
Trang T-B
TT
Chan
Vivien
V
Matsuda
Takeshi
T
Hirst
Stuart J
SJ
D000276:Adjuvants, Immunologic / Q000502:physiology*; D000328:Adult; D000368:Aged; D019138:Antibodies, Blocking / Q000494:pharmacology; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D002478:Cells, Cultured; D054413:Chemokine CCL11; D019742:Chemokines, CC / Q000378:metabolism; D024042:Collagen Type I / Q000502:physiology*; D016207:Cytokines / Q000235:genetics / Q000378:metabolism*; D016326:Extracellular Matrix Proteins / Q000502:physiology; D005260:Female; D005353:Fibronectins / Q000502:physiology*; D005786:Gene Expression Regulation / Q000276:immunology; D006801:Humans; D019012:Integrin beta1 / Q000276:immunology / Q000502:physiology*; D007375:Interleukin-1 / Q000502:physiology; D007424:Intracellular Fluid / Q000276:immunology / Q000378:metabolism; D008168:Lung / Q000276:immunology / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009130:Muscle, Smooth / Q000166:cytology / Q000276:immunology / Q000378:metabolism*
D000276:Adjuvants, Immunologic; D019138:Antibodies, Blocking; D000911:Antibodies, Monoclonal; C515456:CCL11 protein, human; D054413:Chemokine CCL11; D019742:Chemokines, CC; D024042:Collagen Type I; D016207:Cytokines; D016326:Extracellular Matrix Proteins; D005353:Fibronectins; D019012:Integrin beta1; D007375:Interleukin-1